Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion type Assertion NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_head.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_provenance.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion evidence source_evidence_literature NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_provenance.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion SIO_000772 16507781 NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_provenance.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion wasDerivedFrom gad-20150221 NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_provenance.
- NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_assertion wasGeneratedBy ECO_0000203 NP87185.RALZDB7QlgxKA1PsX7psKjpUfU9Vff3ERwuVmTpnmr5Kg130_provenance.